ResMed Inc (RMD)
Operating profit margin
| Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating income (ttm) | US$ in thousands | 1,687,397 | 1,612,040 | 1,560,356 | 1,418,207 | 1,319,892 | 1,213,942 | 1,140,029 | 1,145,129 | 1,131,871 | 1,112,000 | 1,045,594 | 1,014,111 | 1,000,285 | 986,526 | 975,687 | 948,692 | 903,675 | 885,285 | 879,359 | 855,452 |
| Revenue (ttm) | US$ in thousands | 5,146,330 | 5,021,540 | 4,926,780 | 4,807,490 | 4,546,017 | 4,444,877 | 4,364,797 | 4,235,737 | 4,222,994 | 4,015,671 | 3,763,271 | 3,624,405 | 3,578,126 | 3,539,492 | 3,443,759 | 3,348,896 | 3,196,825 | 3,091,065 | 3,091,753 | 3,027,899 |
| Operating profit margin | 32.79% | 32.10% | 31.67% | 29.50% | 29.03% | 27.31% | 26.12% | 27.03% | 26.80% | 27.69% | 27.78% | 27.98% | 27.96% | 27.87% | 28.33% | 28.33% | 28.27% | 28.64% | 28.44% | 28.25% |
June 30, 2025 calculation
Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $1,687,397K ÷ $5,146,330K
= 32.79%
The analysis of ResMed Inc.'s operating profit margin over the specified period reveals a generally stable profitability level with modest fluctuations. From September 30, 2020, through December 31, 2024, the operating profit margin primarily hovered within a narrow range of approximately 26.12% to 28.64%. During this interval, the margins exhibited slight variations, suggesting a relatively steady operational efficiency amidst market and strategic changes.
Notably, starting in late 2024, there is an observable upward trend in the operating profit margin, rising from 26.12% at the end of 2024 to notably higher levels in subsequent quarters—culminating at 32.79% by June 30, 2025. This increase indicates an improvement in operational efficiency, possibly driven by factors such as cost management, product margin enhancements, or revenue growth.
Overall, the period from 2020 through mid-2025 shows that ResMed has maintained a consistent operating profit margin, with a recent favorable trend towards increased profitability. The margin's upward trajectory in the latest periods suggests positive operational developments that could improve the company's financial performance relative to previous years.
Peer comparison
Jun 30, 2025